Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypertension

  Free Subscription


Articles published in Nephrol Dial Transplant

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    March 2023
  1. SYMONIDES B, Lewandowski J, Malyszko J
    Resistant hypertension in dialysis.
    Nephrol Dial Transplant. 2023 Mar 10:gfad047. doi: 10.1093.
    PubMed     Abstract available


    December 2022
  2. BUREAU C, Jamme M, Schurder J, Bobot M, et al
    Nephrosclerosis in young patients with malignant hypertension.
    Nephrol Dial Transplant. 2022 Dec 7:gfac324. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  3. BONIFANT G, Weir MR
    The role of blood pressure control in the prevention of cardiorenal disease in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2022 Nov 30:gfac313. doi: 10.1093.
    PubMed    


  4. GROEN IN 'T WOUD S, Gobino A, Roeleveld N, van den Heuvel LPWJ, et al
    Kidney injury rates after unilateral nephrectomy in childhood-a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2022;37:2457-2473.
    PubMed     Abstract available


    October 2022
  5. MALHOTRA R, Katz R, Kimmel PL, Vasan RS, et al
    Biomarkers of kidney tubule injury and dysfunction and risk of incident hypertension in community-living individuals: results from the multi-ethnic study of atherosclerosis.
    Nephrol Dial Transplant. 2022 Oct 28. pii: 6779687. doi: 10.1093.
    PubMed    


    September 2022
  6. GEORGIANOS PI, Tziatzios G, Roumeliotis S, Vaios V, et al
    Effect of angiotensin converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2022 Sep 7. pii: 6693715. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  7. CAVERO T, Aunon P, Caravaca-Fontan F, Trujillo H, et al
    Thrombotic microangiopathy in patients with malignant hypertension.
    Nephrol Dial Transplant. 2022 Aug 24. pii: 6674778. doi: 10.1093.
    PubMed     Abstract available


  8. ASCHER SB, Scherzer R, Estrella MM, Berry JD, et al
    Kidney tubule health, mineral metabolism and adverse events in persons with CKD in SPRINT.
    Nephrol Dial Transplant. 2022;37:1637-1646.
    PubMed     Abstract available


  9. LEE JY, Park JT, Joo YS, Lee C, et al
    Association of blood pressure with cardiovascular outcome and mortality: results from the KNOW-CKD study.
    Nephrol Dial Transplant. 2022;37:1722-1730.
    PubMed     Abstract available


  10. LOMBARI P, Mallardo M, Petrazzuolo O, Nagoth JA, et al
    miRNA-23a modulates sodium-hydrogen exchanger 1 expression: studies in medullary thick ascending limb of salt induced hypertensive rats.
    Nephrol Dial Transplant. 2022 Aug 3. pii: 6654749. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  11. HAUGEN AJ, Hallan S, Langberg NE, Dahle DO, et al
    Increased risk of ischaemic heart disease after kidney donation.
    Nephrol Dial Transplant. 2022;37:928-936.
    PubMed     Abstract available


  12. WUERZNER G, Pruijm M, Burnier M
    Defining intradialytic hypertension: the importance of measuring blood pressure accurately.
    Nephrol Dial Transplant. 2022 Apr 1. pii: 6562093. doi: 10.1093.
    PubMed    


    March 2022
  13. SCHMIEDER RE
    Renal denervation: where do we stand and what is the relevance to the nephrologist?
    Nephrol Dial Transplant. 2022;37:638-644.
    PubMed     Abstract available


    February 2022
  14. AGARWAL R
    Spironolactone and chlorthalidone-old drugs, new uses-but approach with caution.
    Nephrol Dial Transplant. 2022;37:407-408.
    PubMed    


  15. BORRELLI S, Mallamaci F, Chiodini P, Garofalo C, et al
    Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease.
    Nephrol Dial Transplant. 2022 Feb 7. pii: 6523367. doi: 10.1093.
    PubMed    


    December 2021
  16. ZOCCALI C, Ortiz A, Blumbyte IA, Rudolf S, et al
    Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges.
    Nephrol Dial Transplant. 2021;37.
    PubMed     Abstract available


  17. MALLAMACI F, Pisano A, Tripepi G
    Hypertension management in chronic kidney disease.
    Nephrol Dial Transplant. 2021;36:2194-2195.
    PubMed    


    November 2021
  18. SARAFIDIS P, Burnier M
    Sex differences in the progression of kidney injury and risk of death in CKD patients: is different ambulatory blood pressure control the underlying cause?
    Nephrol Dial Transplant. 2021;36:1965-1967.
    PubMed    


  19. MINUTOLO R, Gabbai FB, Agarwal R, Garofalo C, et al
    Sex difference in ambulatory blood pressure control associates with risk of ESKD and death in CKD patients receiving stable nephrology care.
    Nephrol Dial Transplant. 2021;36:2000-2007.
    PubMed     Abstract available


    August 2021
  20. SHOJI T, Fujii H, Mori K, Nakatani S, et al
    Associations of cardiovascular disease and blood pressure with cognition in hemodialysis patients: The Osaka Dialysis Complication Study.
    Nephrol Dial Transplant. 2021 Aug 30. pii: 6359825. doi: 10.1093.
    PubMed     Abstract available


  21. SIGNORINI L, Zaza G, Gambaro G
    The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomes.
    Nephrol Dial Transplant. 2021;36:1766.
    PubMed    


  22. BURNIER M
    Renal denervation for patients with chronic kidney disease and resistant hypertension: effective and safe but still not the panacea.
    Nephrol Dial Transplant. 2021 Aug 12. pii: 6349187. doi: 10.1093.
    PubMed    


    July 2021
  23. ADROGUE HE, Evans A, Murad DN, Nguyen H, et al
    Long-term outcomes of kidney donors with fibromuscular dysplasia.
    Nephrol Dial Transplant. 2021;36:1538-1545.
    PubMed     Abstract available


    June 2021
  24. OTT C, Mahfoud F, Mancia G, Narkiewicz K, et al
    Renal denervation in patients with versus without chronic kidney disease: results from the global SYMPLICITY Registry with follow-up data of 3 years.
    Nephrol Dial Transplant. 2021 Jun 9. pii: 6295682. doi: 10.1093.
    PubMed     Abstract available


  25. WU JG, Tong A, Evangelidis N, Manera KE, et al
    Patient and caregiver perspectives on blood pressure in children with chronic kidney disease.
    Nephrol Dial Transplant. 2021 Jun 4. pii: 6292122. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  26. JUNG HH
    On-treatment blood pressure and long-term outcomes in chronic kidney disease.
    Nephrol Dial Transplant. 2021 Apr 3. pii: 6209737. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  27. PRISCHL FC, Rossing P, Bakris G, Mayer G, et al
    Major adverse renal events (MARE): a proposal to unify renal endpoints.
    Nephrol Dial Transplant. 2021;36:491-497.
    PubMed     Abstract available


  28. SATO M, Ishikura K, Ando T, Kikunaga K, et al
    Prognosis and acute complications at the first onset of idiopathic nephrotic syndrome in children: a nationwide survey in Japan (JP-SHINE study).
    Nephrol Dial Transplant. 2021;36:475-481.
    PubMed     Abstract available


    September 2019
  29. MCINTYRE NJ, Shardlow A, Fluck RJ, McIntyre CW, et al
    Determinants of change in arterial stiffness over 5 years in early chronic kidney disease.
    Nephrol Dial Transplant. 2019 Sep 18. pii: 5571279. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: